Healthcare -
Biotechnology - NASDAQ - US
$ 2.2
7.84 %
$ 37 M
Market Cap
-0.5
P/E
OCX - TOTAL EQUITY
Total Equity OCX - OncoCyte Corporation
25.6 M
LAST VALUE
-37.35%
2 YEAR CAGR
49.54%
5 YEAR CAGR
21.62%
10 YEAR CAGR